close 74% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

Home・Aandelen Lijst・CEL-SCI Corp
Search

CEL-SCI Corp

Gesloten

SectorGezondheidszorg

10.69 4.6

Prijsupdate 9 sep 2025, 19:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

9.94

Max

10.7

Belangrijke statistieken

By Trading Economics

Inkomsten

908K

-5.7M

EPS

-1.36

Winstmarge

-118.811

EBITDA

890K

-4.5M

Marktinformatie

By TradingEconomics

Marktkapitalisatie

24M

72M

Vorige openingsprijs

6.09

Vorige sluitingsprijs

10.69

Nieuwssentiment

By Acuity

73%

27%

342 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

N/A / 0.2494 Steun & Weerstand

CEL-SCI Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

9 sep 2025, 23:37 UTC

Populaire aandelen

Stocks to Watch: Oracle, Wearable Devices, GameStop

DJ

Lezen

9 sep 2025, 20:41 UTC

Winsten

Oracle's Backlog Surges With Major Customer Deals in 1Q

DJ

Lezen

9 sep 2025, 20:30 UTC

Winsten

GameStop 2Q Sales, Profit Rise

DJ

Lezen

9 sep 2025, 23:19 UTC

Marktinformatie

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

DJ

Lezen

9 sep 2025, 21:35 UTC

Winsten

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

DJ

Lezen

9 sep 2025, 21:32 UTC

Winsten

Oracle's Backlog Swells With Big Customer Deals -- Update

DJ

Lezen

9 sep 2025, 21:02 UTC

Acquisities, Fusies, Overnames

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

DJ

Lezen

9 sep 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

9 sep 2025, 20:33 UTC

Winsten

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

DJ

Lezen

9 sep 2025, 20:26 UTC

Winsten

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

DJ

Lezen

9 sep 2025, 20:23 UTC

Winsten

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

DJ

Lezen

9 sep 2025, 20:12 UTC

Winsten

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

DJ

Lezen

9 sep 2025, 20:10 UTC

Winsten

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

DJ

Lezen

9 sep 2025, 20:10 UTC

Winsten

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

DJ

Lezen

9 sep 2025, 20:09 UTC

Winsten

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

DJ

Lezen

9 sep 2025, 20:09 UTC

Winsten

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

DJ

Lezen

9 sep 2025, 20:08 UTC

Winsten

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

DJ

Lezen

9 sep 2025, 20:08 UTC

Winsten

Oracle 1Q Operating Income Was $4.3 B >ORCL

DJ

Lezen

9 sep 2025, 20:08 UTC

Winsten

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

DJ

Lezen

9 sep 2025, 20:08 UTC

Winsten

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

DJ

Lezen

9 sep 2025, 20:07 UTC

Winsten

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

DJ

Lezen

9 sep 2025, 20:06 UTC

Winsten

Oracle 1Q Software Revenue $5.72B >ORCL

DJ

Lezen

9 sep 2025, 20:06 UTC

Winsten

Synopsys 3Q Adj EPS $3.39 >SNPS

DJ

Lezen

9 sep 2025, 20:06 UTC

Winsten

Oracle 1Q Cloud Revenue $7.19B >ORCL

DJ

Lezen

9 sep 2025, 20:05 UTC

Winsten

Oracle 1Q Rev $14.93B >ORCL

DJ

Lezen

9 sep 2025, 20:05 UTC

Winsten

Oracle 1Q EPS $1.01 >ORCL

DJ

Lezen

9 sep 2025, 20:05 UTC

Winsten

Synopsys 3Q EPS $1.50 >SNPS

DJ

Lezen

9 sep 2025, 20:05 UTC

Winsten

Oracle 1Q Services Revenue $1.35B >ORCL

DJ

Lezen

9 sep 2025, 20:05 UTC

Winsten

Oracle 1Q Adj EPS $1.47 >ORCL

DJ

Lezen

9 sep 2025, 20:05 UTC

Winsten

Oracle 1Q Hardware Revenue $670M >ORCL

DJ

Lezen

Peer Vergelijking

Prijswijziging

CEL-SCI Corp Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan CEL-SCI Corp - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

N/A / 0.2494Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bullish Evidence

There is one bullish event.

Lange Termijn

Weak Bearish Evidence

There is one bearish event.

Sentiment

By Acuity

342 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

749.85

↑ +1.61%

JNJ

Johnson and Johnson

177.08

↓-0.6%

ABBV

AbbVie Inc

210.45

↑ +0.22%

UNH

UnitedHealth Group Inc

348.61

↑ +8.84%

NVO

Novo Nordisk A-S

54.26

↓-0.09%
help-icon Live chat